Bibliography
- ANDRIES K, VERHASSELT P, GUILLEMOUNT J et al.: A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis Science (2005) 307: 223–227.
- LEE RE, PROTOPOPOVA M, CROOKS E et al: Combinatorial lead optimization of [1,2]-diamines bases on ethambutol as potential antituberculosis preclinical candidates. I Comb. Chem. (2003) 5:172–187.
- JIA L, TOMASZEWSKI JE, HANRANHAN C et al: Pharmacodynamics and pharmacokinetics of SQ-109, anew diamine-based antitubercular drug. Br. Pharmacol (2005) 144:80–87.
- ALCALA L, RUIZ-SERRANO MJ, TUREGANO CP-F et al: LI vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs. Antimicrob. Agents Chemother. (2003) 47:416–417.
- BARBACHYN MR, HUTCHINSON DK, BRICKNER SJ et al: Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. J. Med. Chem. (1996) 39:680–685.
- SBARDELLA G, MAT A, ARTICO M et al: Synthesis and in vitro antimycobacterial activity of novel 3-(1H-pyrrol 1 -yl) 2 oxazolidinone analogues of PNU-100480. Bioorg. Med. Chem. Lett. (2004) 14:1537–1541.
Website
- http://www.thalliance/org TB Alliance website.